Literature DB >> 12673187

MIBG imaging for selecting heart failure patients for defibrillator therapy: a first step.

Colin D Shafer, James E Udelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673187     DOI: 10.1067/mnc.2003.393

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  22 in total

1.  ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines).

Authors:  Gabriel Gregoratos; Jonathan Abrams; Andrew E Epstein; Roger A Freedman; David L Hayes; Mark A Hlatky; Richard E Kerber; Gerald V Naccarelli; Mark H Schoenfeld; Michael J Silka; Stephen L Winters
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

2.  Ability of heart rate variability to predict prognosis in patients with advanced congestive heart failure.

Authors:  W Jiang; W R Hathaway; S McNulty; R L Larsen; K L Hansley; Y Zhang; C M O'Connor
Journal:  Am J Cardiol       Date:  1997-09-15       Impact factor: 2.778

3.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

4.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator.

Authors:  Rishi Arora; Kevin J Ferrick; Tomoaki Nakata; Robert C Kaplan; Michael Rozengarten; Farhana Latif; Kaman Ng; Vanessa Marcano; Sherman Heller; John D Fisher; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

5.  Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.

Authors:  B M Szabó; D J van Veldhuisen; N van der Veer; J Brouwer; P A De Graeff; H J Crijns
Journal:  Am J Cardiol       Date:  1997-04-01       Impact factor: 2.778

Review 6.  New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.

Authors:  H Klein; A Auricchio; S Reek; C Geller
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

7.  Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

Authors:  M S Stanton; M M Tuli; N L Radtke; J J Heger; W M Miles; B H Mock; R W Burt; H N Wellman; D P Zipes
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

8.  Defibrillators in nonischemic cardiomyopathy treatment evaluation.

Authors:  A Kadish; R Quigg; A Schaechter; K P Anderson; M Estes; J Levine
Journal:  Pacing Clin Electrophysiol       Date:  2000-03       Impact factor: 1.976

9.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

10.  Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction.

Authors:  A I McGhie; J R Corbett; M S Akers; P Kulkarni; M N Sills; M Kremers; L M Buja; M Durant-Reville; R W Parkey; J T Willerson
Journal:  Am J Cardiol       Date:  1991-02-01       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.